ESAR - European Surveillance of Antibiotic Resistance
All in-patients; infection and discipline known; 1999 and 2000
Therapy

Type of Infection: Urinary tract infection
  Total Type of therapy
missing Prophylaxis Treatment
N % N % N % N %
Substance 201 28.59 121 17.21 10 1.42 70 9.96
quinolones
aminoglycosides 105 14.94 79 11.24 5 0.71 21 2.99
aminopenicillin + -lact.inh. 82 11.66 40 5.69 2 0.28 40 5.69
sulfonamides 76 10.81 54 7.68 2 0.28 20 2.84
3rd gen. cephalosporins 62 8.82 45 6.40 5 0.71 12 1.71
aminopenicillin 26 3.70 11 1.56 2 0.28 13 1.85
2nd gen. cephalosporins 25 3.56 10 1.42 5 0.71 10 1.42
urinary anti-infectives 24 3.41 14 1.99 3 0.43 7 1.00
acylaminopenicillin + -lact.inh. 17 2.42 9 1.28 2 0.28 6 0.85
carbapenems 13 1.85 6 0.85 - - 7 1.00
glycopeptide 12 1.71 4 0.57 1 0.14 7 1.00
methylpenicillin 9 1.28 5 0.71 - - 4 0.57
acylaminopenicillin 9 1.28 7 1.00 - - 2 0.28
macrolides 8 1.14 3 0.43 - - 5 0.71
1st gen. cephalosporins 7 1.00 4 0.57 2 0.28 1 0.14
antifungals 7 1.00 2 0.28 - - 5 0.71
polypeptides 6 0.85 4 0.57 1 0.14 1 0.14
lincosamides 5 0.71 5 0.71 - - - -
penicillins 4 0.57 1 0.14 1 0.14 2 0.28
tetracyclines 3 0.43 1 0.14 1 0.14 1 0.14
cephalosporin 2 0.28 1 0.14 - - 1 0.14
Total 703 100.00 426 60.60 42 5.97 235 33.43

ESBiC Study Center